NewPoliticsOfCare_map/vaccine_about.html at master · CenterForSpatialResearch/NewPoliticsOfCare_map · GitHub

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
<!DOCTYPE html>
<html>
<head>

	  <meta charset="UTF-8">
    <title>Mapping the New Politics of Care</title>

    <meta charset="UTF-8">
<link href="https://fonts.googleapis.com/css2?family=Open+Sans:ital,wght@0,300;0,400;1,300&display=swap" rel="stylesheet">
    <!-- <link rel="stylesheet" type="text/css" href="css/bootstrap.min.css"> -->
    <link rel="stylesheet" type="text/css" href="css/dc.css"/>
  <script src='https://api.mapbox.com/mapbox.js/v3.1.1/mapbox.js'></script>
  <script src="https://api.mapbox.com/mapbox-gl-js/v1.10.1/mapbox-gl.js"></script>
  <link href='https://api.mapbox.com/mapbox-gl-js/v1.10.1/mapbox-gl.css' rel='stylesheet' />

  <link href='https://api.mapbox.com/mapbox.js/v3.1.1/mapbox.css' rel='stylesheet' />
<script src="https://api.mapbox.com/mapbox-gl-js/plugins/mapbox-gl-geocoder/v4.5.1/mapbox-gl-geocoder.min.js"></script>


<link href="https://fonts.googleapis.com/css2?family=Josefin+Sans:wght@700&family=Raleway:wght@600&display=swap" rel="stylesheet">
<link href="https://fonts.googleapis.com/css2?family=Bai+Jamjuree:wght@700&family=Coda+Caption:wght@800&family=Hammersmith+One&display=swap" rel="stylesheet">
    <link rel="stylesheet" type="text/css" href="css/geocoder.css"/>
    <link rel="stylesheet" type="text/css" href="css/vaccine.css"/>

<script src="https://cdn.jsdelivr.net/npm/es6-promise@4/dist/es6-promise.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/es6-promise@4/dist/es6-promise.auto.min.js"></script>
<!--
  <script type="text/javascript" src="js/mapbox-gl.js"></script>
-->
<script src="https://code.jquery.com/jquery-1.12.4.min.js"
        integrity="sha384-nvAa0+6Qg9clwYCGGPpDQLVpLNn0fRaROjHqs13t4Ggj3Ez50XnGQqc/r8MhnRDZ"
        crossorigin="anonymous">
</script>
<script src="js/jquery.mousefollow.js"></script>
<link href="https://cdn.jsdelivr.net/npm/select2@4.1.0-beta.1/dist/css/select2.min.css" rel="stylesheet" />
<script src="https://cdn.jsdelivr.net/npm/select2@4.1.0-beta.1/dist/js/select2.min.js"></script>
    <style>

      .mapMenu{
        width:49%;
      }
      #map{
        overflow:hidden;
      }
      #mapPopup{
        overflow:hidden;
      }
      .vac{
      }
      #map{
/*        border:1px solid black;
*/      }
      #map2{
/*        border:1px solid black;
*/      }
      #columns1{
        position:absolute;
        top:125px;
        z-index:999;
        width:30hw;
        left:10px;
      }
      #columns2{
        position:absolute;
        top:125px;
        right:10px;
        z-index:999;
        width:30hw;
      }
      .measures1{
        padding:5px;
        margin:2px;
        border:1px solid black;
        background-color:#fff;
        display:inline-block;

      }
      .measures2{
        padding:5px;
        margin:2px;
        border:1px solid black;
        background-color:#fff;
        display:inline-block;
      }
      #mapPop{
        position:absolute;
        top:200px;
        left:200px;
        z-index:9999;
        background-color:rgba(255,255,255,.8);
        padding:5px;
        filter: drop-shadow(1px 1px 10px rgba(0,0,0,.2));
        visibility:hidden;
      }
      #title1{
        position:fixed;
        left:10px;
        z-index:9999;
        top:165px;
        font-size:18px;
        width:30%;
      }
      #title2{
        position:fixed;
        right:10px;
        z-index:9999;
        top:165px;
        font-size:18px;
        width:30%;
        text-align:right;
      }
      .arrow {
        border: solid black;
        border-width: 0 1px 1px 0;
        display: inline-block;
        padding: 5px;
        margin-left:-25px;
        margin-bottom:2px;
      }
      .down {
        transform: rotate(45deg);
        -webkit-transform: rotate(45deg);
      }
      .mapboxgl-ctrl-bottom-right {
        bottom:60px;
      }
      #about{
        position:fixed;
        top:10px;
        right:10px;
        color:#fff;
        z-index:9999;
        font-size:40px;
      }

      #left{
        position:absolute;
        left:0px;
        top:80px;
        padding:2%;
        font-size:12px;
        width:65%;
      }
      .aboutTitle{
        color:#000;
        width: 100%;
        border: none;
        text-align: left;
        outline: none;
        font-size:20px;
        padding:10px;
        line-height:175%;
        font-weight:bold;
        background-color: gold;
      }
      #credits{
          position:absolute;
          top:100px;
          left:75%;
          width:15%;
/*          max-width:700px;
*/          padding:5%;
          font-size:20px;
          line-height:150%;
          margin-bottom:0px;
          padding-bottom:0px;
      }
      #aboutText{
        position:relative;
        top:0px;
        left:0px;
        padding:5%;
        max-width:700px;
        padding-bottom:0px;
        font-size:20px;
      }
      .aboutSubtitle{
        font-size:20px;
        font-weight:bold;
        margin-top:40px;
      }
      .answer{
        padding: 0 18px;
/*        max-height: 0;
*/        overflow: hidden;
        transition: max-height 0.3s ease-out;
        background-color: #ffffff;
        padding-left:30px;
        font-size:16px;
        padding-top:0px;
      }
      li a{
        text-decoration:underline;
      }
      li{
        padding-bottom:10px;
      }
      sup{
        font-size:8px;
      }
      #nav{
        font-size:16px;
        color:#fff;
        position:fixed;
        right:10px;
        top:10px;
        z-index:99999;
        padding:5px;
        border:1px solid white;
      }
      #nav a{
        color:#fff;
      }
      #brand a{
        color:#fff;
      }
    </style>

</head>

<body>
  <div id="nav"><a href="vaccine.html">Back to Map</a></div>
  <div id="credits">
       Project Directors:<br><br>
        <div class="names">
        <strong>Gregg Gonsalves</strong>, Assistant Professor, Yale School of Public Health and Co-Director Yale Global Health Justice Partnership<br><br>
        <strong>Laura Kurgan</strong>, Professor of Architecture, GSAPP and Director Center for Spatial Research(CSR), Columbia University.<br>
        </div>
        <br>
        Project Team: <br><br>
        <div class="names">
        Map Development and Data Analysis: <br><br>
        <strong>Dare Brawley</strong>, Assistant Director, Center for Spatial Research, Columbia University<br><br>
        <strong>Jia Zhang</strong>, Mellon Associate Research Scholar, Columbia Center for Spatial Research<br><br>
        <strong>Suzan Iloglu</strong>, Postdoctoral Research Associate, Yale School of Public Health<br><br>
        <strong>Thomas Thornhill</strong>, Research Associate, Yale School of Public Health<br><br>
      </div>

    </div>
  </div>

<div id="head">
  <span id="brand"><a href="index.html">MAPPING THE NEW POLITICS OF CARE</a>  | Vaccine Allocation Phase 1a</span><br>
  <div id="subtitle">The maps you are looking at compare COVID-19 vaccine distribution strategies that account for vulnerability and risk in different ways.<br> As of January 18th, when some states initiated Phase 1b, 22,578,375 doses of vaccine had been distributed to states. Our map is based on this number.</div>
</div>
  <div id = "left">
<div id="aboutText"><p><strong>Mapping the New Politics of Care: Inequality and Vaccine Redistribution Within Phase 1a</strong></p>

<p>All people in the United States have been granted the right to have access to free, safe, and effective COVID-19 vaccines.<sup>1</sup> But due to the limited doses available, states have enacted policies prioritizing specific groups based on reasonable—but subjective—weighing of scientific, practical, and ethical evidence and values.</p>

<p>The goal of this map is to examine how prioritizing different groups for vaccination shifts the terrain of vaccine allocation and impacts which communities are protected first.<sup>2</sup></p>
</div>


<div class="aboutTitle"> Background: Covid-19 Vaccine Distribution and Allocation in The United States</div>
 <div class="answer">
<p>The federal government, through Operation Warp Speed, is responsible for purchasing and distributing COVID-19 vaccines to states (and other jurisdictions and agencies).<sup>3</sup> As supplies are limited, the federal government is distributing vaccines to states in direct proportion to their adult population.<sup>4</sup> While there is no binding rule on how states (and other jurisdictions and agencies) should allocate limited vaccines, so far the majority of states have followed the Centers for Disease Control’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) COVID-19 Vaccines Work Group recommendations.<sup>5</sup> </p>

<p>ACIP’s vaccine prioritization recommendations are made with the following goals:
Decrease death and serious disease as much as possible
Preserve functioning of society
Reduce the extra burden COVID-19 is having on people already facing disparities <sup>6,7,8</sup> </p>
<p>ACIP determined that in Phase 1a, the first groups to be prioritized should consist of health-care personnel and long-term care facility residents. In its guidance, ACIP was explicit in citing evidence that prioritizing Phase 1a groups would mitigate health inequities due to “the disproportionate representation of racial and ethnic minority groups” among low-wage health-care personnel and that the lowest-rated long-term care facilities “are more likely to serve patients experiencing social or economic disadvantage and are more likely to have COVID-19-associated outbreaks.” <sup>9</sup>
</p>
<p>

<i>It is in the spirit of ACIP’s efforts to mitigate health inequities that we set parameters for our map.</i>
</p>
<p>
Based on the prioritization recommendation of the National Academies of Sciences, Engineering, and Medicine Committee on Equitable Allocation of Vaccine for the Novel Coronavirus, we have used the CDC’s Social Vulnerability Index (SVI) to identify areas as vulnerable.<sup>10</sup>
</p>
</div>

<div class="aboutTitle"> Mapping Priorities</div>


 <div class="answer">
   <p>
The map enables the comparison of four COVID-19 vaccine allocation scenarios at the county level.
</p>
<p>

<ol>
<li><strong>Adult population</strong><br>
An extension of the federal government’s vaccine distribution rationale from the state level to the county level
</li>
<li><strong>Phase 1a</strong><br>
ACIP’s prioritization of health-care personnel and long-term care facility residents
</li>
<li><strong>Phase 1a weighted by SVI (incl. race/ethnicity)</strong><br>
Suballocation within Phase 1a by CDC’s Social Vulnerability Index
</li>
<li><strong>Phase 1a weighted by SVI (excl. race/ethnicity)</strong><br>
Suballocation within Phase 1a by CDC’s Social Vulnerability Index (excl. race/ethnicity)
</li>
</ol>
</p>
<p>

These comparisons highlight the trade-offs of competing strategies: between each pair of maps, you will see the respective number of vaccine doses allocated to each county and therefore which populations and communities are protected first.
</p>
<p>

As we switch between the various allocation methods, the number of doses allocated will vary by county but the total number of vaccines distributed to the state will remain the same.
</p>
</div>

<div class="aboutTitle">Estimation Methods</div>


 <div class="answer">
<p>
<div class="aboutSubtitle">Adult population</div>
The number of vaccine doses for each county is allocated based on the number of actual doses distributed to the state and in proportion to the estimated adult population of each county.
<br>
<img src="equations/adult_pop.png" width="720px">
</p>

<p>
<div class="aboutSubtitle">Phase 1a </div>
The number of vaccine doses for each county is allocated in proportion to the estimated number of health-care personnel and residents of long-term care facilities.
<br>
<img src="equations/phase1a.png" width="720px">
</p>

<p>
<div class="aboutSubtitle">Phase 1a weighted by SVI (incl. race/ethnicity)</div>
County Phase 1a estimates are weighted by the county’s Social Vulnerability Index (SVI) ranking, an unweighted average of the population percentages of SVI’s 15 social factors.
<br>
<img src="equations/svi.png" width="720px">
</p>

<p>
<div class="aboutSubtitle">Phase 1a weighted by SVI (excl. race/ethnicity)</div>
The calculation is similar to Phase 1a weighted by SVI (incl. race/ethnicity), except that here SVI is composed of only 14 social factors as the race/ethnicity variable (i.e., “Minority Status”) is excluded.
<br>
<img src="equations/sviMinus.png" width="720px">
<br>
</p>
</div>


<div class="aboutTitle">Case Study: Comparing Allocations in Prince George’s County, Maryland</div>

 <div class="answer">
<p>

As of January 18th, Maryland had been allocated 417,925 first doses, or enough to cover ~9.0% of  its estimated adult population of 4,677,166. Selecting Prince George’s County, a suburb of Washington DC and the county with second largest population in Maryland, illustrates our points about equity in allocation:</p>
<p>

<i>Adult Population</i><br>
If vaccines were distributed in proportion Proportional to the county’s adult population, Prince George’s would be allocated 63,051 doses (~15.1% of the state’s total doses).
</p>
<img src="formulas_adultpop.png" width="650px">
<br><br>
<p>

<i>Phase 1a</i><br>
If instead vaccines were distributed in proportion Proportional to the county’s Phase 1a population,  Prince George’s would be allocated just 60,494 doses (~14.5%). Compared to allocating by the adult population, using the allocating by Phase 1a population would decrease the county’s allotment by 2,556 doses (a change of -4.1%).
</p>
<img src="formulas_1a.png" width="650px">
<br><br>
<p>

<i>Phase 1a weighted by SVI </i><br>
If doses were distributed in proportion Proportional to the county’s Phase 1a population weighted by SVI, Prince George’s would be allocated 72,468 doses (~17.3% of the state's total doses). Adding SVI SVI is factored in  would give 11,974 doses to the county c Compared to allocating by just Phase 1a population , weighting Phase 1a by SVI increases the county’s allotment of doses by 11,974 (an increase of 19.8%)
</p>
<img src="formulas_svi.png" width="650px">
<br><br>
<p>
<i>Phase 1a weighted by SVI vs Phase 1a weighted by SVI (excl. race/ethnicity)</i><br>
If a modified SVI measure that excludes race and/or ethnicity is used to weight the Phase 1a population tBut if the SVI race and/or ethnicity factor is excluded from the Phase 1a weighting by SVI, then Prince George’s would be allotted only 61,830 doses (~14.8% of the state’s total doses). Compared to Phase 1a weighted by SVI, excluding the race and or ethnicity factor gives 10,638 fewer doses to the county decreases the doses the county would recieve by 10,638 (a decrease of-17.2%) due to Prince George’s larger proportion of non-white non-hispanic people—and returns its allocation to a level comparable with Phase 1a population alone (60,494 doses).
</p>
<img src="formulas_sviMinus.png" width="650px">
<br><br>
</div>


<div class="aboutTitle">Trade-offs</div>

 <div class="answer">
<p>

As the map shows, no scenario is neutral. Each prioritization reflects an explicit or implicit valuation, as well as the logistical challenges of distributing vaccine doses to hundreds of millions of Americans as quickly as possible. This project visualizes the differences and trade-offs between each of these choices in the hopes that a more nuanced understanding of the options will lead to more informed and ethical outcomes.
</p>
<p>

Indeed, even if we do not base dose allocations on prepandemic vulnerability directly, understanding who is likely to be left behind might enable states to make targeted investments in outreach, distribution facilities, and health-care capacity in order to mitigate the impact of existing inequality.
</p>
<p>
However, data from state health departments already show that vaccinations among Black Americans trail their white counterparts—even in the above population groups.
</p>
</div>


<div class="aboutTitle">Data</div>

 <div class="answer">
<p>
Vaccine distribution data are from the CDC’s COVID-19 Vaccine Distribution Allocations by Jurisdiction for the Pfizer<sup>11</sup> and Moderna<sup>12</sup> vaccines.
</p>
<p>
Adult population estimates are from the American Community Survey 5-Year Data (2015–2019) .
</p>
<p>
Health-care personnel estimates are from the 2018 Census Business Patterns (CBP),<sup>14</sup> defined by Healthcare and Social Assistance Sector (NAICS 62) excluding Social Assistance (NAICS 624).
</p>
<p>
Long-term care facility (LTCF) residents estimates are from the Centers for Medicare & Medicaid Services (CMS) Provider Information dataset for nursing homes including rehab services.<sup>15</sup>
</p>
<p>
SVI rankings were estimated by applying the most recent SVI methodology<sup>16</sup> to the American Community Survey 5-Year Data (2015–2019).<sup>17</sup>
</p>
</div>
<div class="aboutTitle">References</div><br>

<div class="answer">
  <ol>
  <li>Executive Order 13962, 85 Fed. Reg. 79777 (December 12, 2020),

    <a href="https://www.federalregister.gov/documents/2020/12/11/2020-27455/ensuring-access-to-united-states-government-covid-19-vaccines" target="_blank">https://www.federalregister.gov/documents/2020/12/11/2020-27455/ensuring-access-to-united-states-government-covid-19-vaccines</a>.


</li>
<li>
  This map is a companion to our project Mapping the New Politics of Care: 1 Million Community Health Workers, which explores how community health workers (CHWs) might address both the immediate needs of communities during this pandemic as well as long-standing health disparities across the United States.
</li>
<li>
These jurisdictions and agencies consist of the 50 states, six metropolitan cities, eight territories, and five federal agencies.
</li>
<li>
Lisa Simunaci, “Pro Rata Vaccine Distribution Is Fair, Equitable,” Department of Defense News, December 11, 2020,  <a href="https://www.defense.gov/Explore/News/Article/Article/2441698/pro-rata-vaccine-distribution-is-fair-equitable/" target="_blank">https://www.defense.gov/Explore/News/Article/Article/2441698/pro-rata-vaccine-distribution-is-fair-equitable/</a>.
</li>
<li>
KFF’s State Health Facts. Data source: KFF analysis of state websites and COVID-19 vaccine plans, “State COVID-19 Vaccine Priority Populations,”  <a href="https://www.kff.org/coronavirus-covid-19/issue-brief/the-covid-19-vaccination-line-an-update-on-state-prioritization-plans/" target="_blank">https://www.kff.org/coronavirus-covid-19/issue-brief/the-covid-19-vaccination-line-an-update-on-state-prioritization-plans/</a>.
</li>
<li>
Centers for Disease Control and Prevention, “When Vaccine Is Limited, Who Should Get Vaccinated First?,” updated January 8, 2021,  <a href="https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations.html" target="_blank">https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations.html</a>.
</li>
<li>
Formally, ACIP categorizes these considerations in the evidence tables of their recommendations as either scientific evidence of SARS-CoV-2 epidemiology (“Science”), vaccination program implementation (“Implementation”), and ethical principles (“Ethics”): maximize benefits and minimize harms, promote justice, mitigate health inequities, and promote transparency.
</li>
<li>
Nancy McClung, Mary Chamberland, Kathy Kinlaw, Dayna Bowen Matthew, Megan Wallace, Beth P. Bell, Grace M. Lee, et al., “The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine—United States, 2020,” Morbidity and Mortality Weekly Report 69, no. 47 (2020): 1782, DOI:  <a href="http://dx.doi.org/10.15585/mmwr.mm6947e3" target="_blank">http://dx.doi.org/10.15585/mmwr.mm6947e3</a>.
</li>
<li>
Kathleen Dooling, Nancy McClung, Mary Chamberland, Mona Marin, Megan Wallace, Beth P. Bell, Grace M. Lee, H. Keipp Talbot, José R. Romero, and Sara E. Oliver, “The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine—United States, 2020,” Morbidity and Mortality Weekly Report 69, no. 49 (2020): 1857, DOI:  <a href="http://dx.doi.org/10.15585/mmwr.mm6949e1" target="_blank">http://dx.doi.org/10.15585/mmwr.mm6949e1</a>.
</li>
<li>
National Academies of Sciences, Engineering, and Medicine, Framework for Equitable Allocation of COVID-19 Vaccine (Washington, DC: National Academies Press, 2020),  <a href="https://doi.org/10.17226/25917" target="_blank">https://doi.org/10.17226/25917</a>.
</li>
<li>
Centers for Disease Control and Prevention, “COVID-19 Vaccine Distribution Allocations by Jurisdiction - Pfizer,” 2020,  <a href="https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/saz5-9hgg" target="_blank">https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/saz5-9hgg</a>.
</li>
<li>
Centers for Disease Control and Prevention, “COVID-19 Vaccine Distribution Allocations by Jurisdiction - Moderna,” 2020,  <a href="https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/b7pe-5nws" target="_blank">https://data.cdc.gov/Vaccinations/COVID-19-Vaccine-Distribution-Allocations-by-Juris/b7pe-5nws</a>.
</li>
<li>
US Census Bureau, “American Community Survey 5-Year Data (2015–2019),” 2020, <a href="https://www.census.gov/data/developers/data-sets/acs-5year.html" target="_blank">https://www.census.gov/data/developers/data-sets/acs-5year.html</a>.
</li>
<li>
US Census Bureau, “2018 County Business Patterns,” 2020,  <a href="https://www.census.gov/programs-surveys/cbp.html" target="_blank">https://www.census.gov/programs-surveys/cbp.html</a>.
</li>
<li>
Centers for Medicare and Medicaid Services, “Nursing homes including rehab services, Provider Information,” 2020,  <a href="https://data.cms.gov/provider-data/dataset/4pq5-n9py" target="_blank">https://data.cms.gov/provider-data/dataset/4pq5-n9py</a>.
</li>
<li>
Centers for Disease Control and Prevention, “CDC Social Vulnerability Index (SVI),” September 4, 2020, <a href="https://www.atsdr.cdc.gov/placeandhealth/svi/index.html" target="_blank">https://www.atsdr.cdc.gov/placeandhealth/svi/index.html</a>.
</li>
<li>
US Census Bureau, “American Community Survey 5-Year Data (2015–2019),” 2020, <a href="https://www.census.gov/data/developers/data-sets/acs-5year.html" target="_blank">https://www.census.gov/data/developers/data-sets/acs-5year.html</a>.
</li>

</div>
</div>


<script type="text/javascript" src="js/d3.js"></script>
<script type="text/javascript" src="js/crossfilter.js"></script>
<script type="text/javascript" src="js/dc.js"></script>
<script type="text/javascript" src="js/queue.v1.min.js"></script>
<script type="text/javascript" src="state_names.js"></script>
<script type="text/javascript" src="nodata.js"></script>
<!--<script type="text/javascript" src="vaccine_cartogram.js"></script> -->
<script>

    </script>

<script type="text/javascript" src="vaccine_allocations.js"></script>

</body>
</html>